Mankind Pharma: Mankind Pharma will buy Bharat Serums, deal done for 13630 crores!

Bharat Serums: After the news of the deal between Bharat Serums and Mankind Pharma, the company's stock saw a rise on Thursday. Mankind's stock is expected to rise for the second consecutive trading session.
Mankind Pharma Bharat Serum Deal: Mankind Pharma said that it will acquire Bharat Serums and Vaccines for around Rs 13,630 crore. A statement from Mankind Pharma said that the company has signed a definitive agreement to acquire a 100 percent stake in Bharat Serums and Vaccines (BSV) at an enterprise value of around Rs 13,630 crore. The company will acquire this stake from Advent International. The company said that this strategic move will help establish Mankind Pharma as a leader in the Indian women's health and reproductive medicine market.
Leading company in women's medicine
Mankind Pharma said that this move is a big achievement for them. This will make the company a leader in the Indian women's health and fertility related medicines market. Along with this, they will also get a good position to make medicines for other important diseases. It is very difficult to make these medicines and the company already has good technology for this. BSV has more than 50 years of experience in biopharmaceuticals. This company makes special types of medicines for women's health.
Prospects in the field of women's medicines
Mankind Pharma's Vice Chairman and MD Rajiv Juneja said the acquisition of BSV is an important milestone in Mankind's journey. With this we have become a leader in the Indian women's health and fertility sector. We believe that there is a huge potential in the women's health and fertility sector. BSV CEO and MD Sanjeev Navangul said, we are one of the few Indian companies that have several indigenously developed complex treatments, which have given better results.
Will the stock see a rise?
After the news of Mankind's acquisition of Bharat Serums and Vaccines (BSV) came, the stock of Mankind Company saw a rise on Thursday. At the end of the trading session, the company's stock closed at Rs 2143.90 with a rise of Rs 38.10 (1.81%). There is a possibility of further rise in the stock on the last trading day of the week. Currently, the market cap of the company is Rs 85,892 crore. The 52-week high of the stock is Rs 2,488.65 and the low is Rs 1,680.50.